Android app Apple app link

From Davids to Goliaths: the GLP-1R gold rush

By Yahoo! Finance   |   1 week ago
From Davids to Goliaths: the GLP-1R gold rush

GLP-1R drugs saw huge success in 2023, generating $37.2 billion in sales. Novo Nordisk and Eli Lilly dominated the market.

Read More

Did you find this insightful?

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.